{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:26:42Z","timestamp":1793467602785,"version":"4.5.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Clinical implications of frailty in myeloproliferative neoplasms (MPN), including essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), are unknown. In this population-based study, all incident cases of MPN from the Ontario cancer registry between 2004 and 2019 (N\u00a0= 10 336; ET\u00a0= 5108; PV\u00a0= 3843; MF\u00a0= 1385) and their matched controls (for age, sex, residence, and income) in a 1:4 ratio were included. Baseline frailty measured using the Johns Hopkins Adjusted Clinical Groups frailty indicator and McIsaac frailty index (mFI), categorized as fit, prefrail, or frail if mFI &amp;lt;0.10, 0.11 to 0.20, &amp;gt;0.20), was significantly higher in ET, PV, and MF compared with matched controls (standardized mean difference of 0.27, 0.27, and 0.28). Over 23%, 20%, and 34% of patients with ET, PV, and MF were frail or prefrail despite a younger age (&amp;lt;65 years) or minimal comorbidities. In Cox proportional regression, frailty was independently associated with worse overall survival (OS) after adjusting for age, sex, and comorbidities compared with mFI-fit patients. The hazard ratios (95% confidence interval) for OS for mFI-prefrail and mFI-frail patients were: 1.6 (1.3-1.9) and 3.6 (2.9-4.4) in ET, 1.3 (1.1-1.5) and 2.7 (2.1-3.4) in PV, and 1.2 (1.0-1.5) and 2.0 (1.5-2.7) in MF. Patients with MPN have a substantially higher prevalence of frailty compared with matched controls, which is associated with reduced OS, independent of age or comorbidities.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023009825","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T16:34:10Z","timestamp":1684168450000},"page":"5014-5026","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-0538","authenticated-orcid":false,"given":"Aniket","family":"Bankar","sequence":"first","affiliation":[{"name":"1Princess Margaret Cancer Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[{"name":"2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9215-475X","authenticated-orcid":false,"given":"Ning","family":"Liu","sequence":"additional","affiliation":[{"name":"2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3193-5872","authenticated-orcid":false,"given":"Matthew","family":"Cheung","sequence":"additional","affiliation":[{"name":"2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"},{"name":"3Sunnybrook Health Sciences Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-6046","authenticated-orcid":false,"given":"Shabbir","family":"Alibhai","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"4Toronto General Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1419-8607","authenticated-orcid":false,"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"issue":"22","key":"2023091115440892100_bib1","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023091115440892100_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009","article-title":"The frailty syndrome: definition and natural history","volume":"27","author":"Xue","year":"2011","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"2023091115440892100_bib3","doi-asserted-by":"crossref","first-page":"M255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care","volume":"59","author":"Fried","year":"2004","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"2023091115440892100_bib4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mds619","article-title":"Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study","volume":"24","author":"Kenis","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"2023091115440892100_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/joim.13019","article-title":"Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden","volume":"287","author":"Hultcrantz","year":"2020","journal-title":"J\u00a0Intern Med"},{"issue":"5","key":"2023091115440892100_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/M17-0028","article-title":"Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study","volume":"168","author":"Hultcrantz","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"2023091115440892100_bib7","first-page":"2489","article-title":"Second malignancies in philadelphia-negative myeloproliferative neoplasms\u2013single-center experience","volume":"34","author":"Kissova","year":"2014","journal-title":"Anticancer Res"},{"issue":"24","key":"2023091115440892100_bib8","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1200\/JCO.2012.42.1925","article-title":"Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study","volume":"30","author":"Hultcrantz","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"2023091115440892100_bib9","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1080\/10428194.2020.1749607","article-title":"Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada","volume":"61","author":"Bankar","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2023091115440892100_bib28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","article-title":"The prevalence and outcomes of frailty in older cancer patients: a systematic review","volume":"26","author":"Handforth","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"2023091115440892100_bib10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"2023091115440892100_bib11","doi-asserted-by":"crossref","first-page":"102476","DOI":"10.1155\/2015\/102476","article-title":"MPNs as inflammatory diseases: the evidence, consequences, and perspectives","volume":"2015","author":"Hasselbalch","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"6","key":"2023091115440892100_bib12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11357-020-00247-4","article-title":"Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis","volume":"42","author":"Marcos-P\u00e9rez","year":"2020","journal-title":"Geroscience"},{"issue":"27","key":"2023091115440892100_bib13","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.31.0664","article-title":"Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study","volume":"29","author":"Caillet","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2023091115440892100_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/annonc\/mdq637","article-title":"Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin\u2013gemcitabine or carboplatin\u2013paclitaxel: NVALT-3 a phase III study","volume":"22","author":"Biesma","year":"2011","journal-title":"Ann Oncol"},{"issue":"13","key":"2023091115440892100_bib15","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ejca.2013.04.027","article-title":"Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: final results of the DOGMES multicentre GINECO trial","volume":"49","author":"Falandry","year":"2013","journal-title":"Eur J Cancer"},{"issue":"6","key":"2023091115440892100_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ejca.2011.06.016","article-title":"Examining five-and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment","volume":"48","author":"Clough-Gorr","year":"2012","journal-title":"Eur J Cancer"},{"issue":"4","key":"2023091115440892100_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jamcollsurg.2015.12.020","article-title":"Inclusion of sarcopenia outperforms the modified frailty index in predicting 1-year mortality among 1,326 patients undergoing gastrointestinal surgery for a malignant indication","volume":"222","author":"Buettner","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"issue":"10206","key":"2023091115440892100_bib18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"2023091115440892100_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/SLA.0000000000002769","article-title":"Derivation and validation of a generalizable preoperative frailty index using population-based health administrative data","volume":"270","author":"McIsaac","year":"2019","journal-title":"Ann Surg"},{"issue":"S1","key":"2023091115440892100_bib20","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1186\/1472-6963-9-S1-A16","article-title":"Using the ACG\u00ae casemix system in population health management programs at Johns Hopkins","volume":"9","author":"Dunbar","year":"2009","journal-title":"BMC Health Serv Res"},{"key":"2023091115440892100_bib21","first-page":"1","volume-title":"Data and Measures in Health Services Research","author":"Prodhan","year":"2016"},{"issue":"8","key":"2023091115440892100_bib22","doi-asserted-by":"crossref","first-page":"E487","DOI":"10.1503\/cmaj.101271","article-title":"Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey","volume":"183","author":"Rockwood","year":"2011","journal-title":"CMAJ"},{"key":"2023091115440892100_bib23","author":"Matheson","year":"2012"},{"issue":"6","key":"2023091115440892100_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simulat Comput"},{"issue":"1","key":"2023091115440892100_bib25","first-page":"1","article-title":"Tukey\u2019s honestly significant difference (HSD) test","volume":"3","author":"Abdi","year":"2010","journal-title":"Encycl Res Des"},{"issue":"3","key":"2023091115440892100_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/0962280214567141","article-title":"Predictive accuracy of novel risk factors and markers: A simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model","volume":"26","author":"Austin","year":"2017","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"2023091115440892100_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0197-2456(00)00104-5","article-title":"Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates","volume":"21","author":"Hsieh","year":"2000","journal-title":"Control Clin Trials"},{"issue":"6","key":"2023091115440892100_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2114\/jpa2.30.259","article-title":"One operational definition by population: the need for local evaluations of frailty","volume":"30","author":"de Souto Barreto","year":"2011","journal-title":"J\u00a0Physiol Anthropol"},{"issue":"11","key":"2023091115440892100_bib30","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jamda.2020.08.014","article-title":"Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care","volume":"21","author":"H\u00e4gg","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"2023091115440892100_bib31","doi-asserted-by":"crossref","first-page":"103618","DOI":"10.1016\/j.ijnurstu.2020.103618","article-title":"Prefrailty in older adults: a concept analysis","volume":"108","author":"Rasiah","year":"2020","journal-title":"Int J Nurs Stud"},{"issue":"3","key":"2023091115440892100_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bjh.17617","article-title":"Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study","volume":"194","author":"Bankar","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"2023091115440892100_bib33","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41375-019-0666-7","article-title":"An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring","volume":"34","author":"Starkman","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"2023091115440892100_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archinte.166.4.418","article-title":"Transitions between frailty states among community-living older persons","volume":"166","author":"Gill","year":"2006","journal-title":"Arch Intern Med"},{"issue":"9","key":"2023091115440892100_bib35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/gerona\/63.9.984","article-title":"Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II","volume":"63","author":"Xue","year":"2008","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"2023091115440892100_bib36","first-page":"383","article-title":"Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies","volume":"46","author":"Puts","year":"2017","journal-title":"Age Ageing"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/17\/5014\/2077032\/blooda_adv-2023-009825-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/17\/5014\/2077032\/blooda_adv-2023-009825-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:44:37Z","timestamp":1694447077000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/17\/5014\/495843\/Prevalence-of-frailty-and-its-association-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":36,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,9,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023009825","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]}}}